Skip to main content
. 2022 Jun 22;118(10):2329–2338. doi: 10.1093/cvr/cvac068

Graphical Abstract.

Graphical Abstract

There was no evidence of an increased risk of major adverse cardiovascular events after vaccination with BNT162b2 or CoronaVac in patients with cardiovascular disease.